Study on the Removal Characteristics of IBP and DCF in Wastewater by CW-MFC with Different Co-Substrates

Abstract

Pharmaceuticals and Personal Care Products (PPCPs) constitute a group of compounds that are challenging to break down and potentially pose risks to both ecosystems and human health when they accumulate in water bodies. This study established and operated small-scale constructed wetland–microbial fuel cells (CW-MFCs) continuously for 60 days, maintaining a hydraulic retention time (HRT) of 3 days. The research aimed to assess the treatment efficiency of wastewater containing Ibuprofen (IBP) and Diclofenac (DCF) using different co-substrates (glucose, sucrose, and sodium acetate) and to analyze the impact of these co-substrates on the composition of bacterial communities within the CW-MFC. After 60 days of operation, CW-MFC achieved removal rates of 89.29% for IBP and 84.10% for DCF. The elimination of IBP was primarily dependent on co-metabolic degradation processes occurring in both the anode and cathode, while DCF removal relied on anodic co-metabolism. Additionally, various co-substrates have an influence on the bacterial community diversity of the anode and cathodes. The possible bacterial groups involved in PPCP degradation were identified. In summary, Glu was identified as a more suitable co-substrate for CW-MFC in the removal of IBP and DCF, while SA as a co-substrate favored the induction and enrichment of EAB in the anodes. These findings offer valuable insights into the potential of CW-MFC for mitigating emerging contaminants.